Table 2 Echocardiographic results and follow up (*1 patient with an event 10 days after CV was excluded due to discontinuation of anticoagulation; abbreviations see text)
Contrast-enhanced TEE | Control group | p value | |
|---|---|---|---|
n | 90 | 90 | |
thrombus detected (%) | 10 (11.1) | 10 (11.1) | |
LAA-flow (m/s) | 0.32 ±0.2 | 0.29 ±0.2 | 0.75 |
LAA-flow ≤ 0.3m/s (%) | 7 (70) | 8 (80) | 0.606 |
SEC (no/minor-moderate/ marked) | 2 / 6 / 2 | 0 / 4 / 6 | 0.111 |
LA diameter (mm) | 47.6±7.2 | 50.1±6.1 | 0.429 |
thrombus excluded / unclear | 80 (88.9) | 80 (88.9) | |
LAA-flow (m/s) | 0.47 ±0.2 | 0.48 ±0.2 | 0.711 |
SEC (no/minor-moderate/ marked) | 35 / 38 / 7 | 25 / 48 / 7 | 0.243 |
LA diameter (mm) | 46.5±6.3 | 46.6±7.3 | 0.895 |
CV performed (%) | 74 (82.2) | 76 (84.4) | 0.514 |
CV related events (%) | 0 (0)* | 3 (3.9) | 0.084 |